Friday, December 27, 2024

An unlikely ally fighting cancer

How poop transplants can fight cancer.
View in browser
Bloomberg

Prognosis is now exclusively for Bloomberg.com subscribers. As a loyal reader, we'll keep sending it to you for a limited time. If you'd like to continue receiving Prognosis, and gain unlimited digital access to all of Bloomberg.com, we invite you to subscribe now at the special rate of $129 for your first year (usually $299).

Hi, it's Jason in Melbourne. We keep learning cool things about the trillions of germs that live on and in us, and ways we can harness them to improve our health. But, before we get into that... 

Today's must-reads

You are what (your bugs) eat

Immunotherapy has emerged as one of the most exciting frontiers in medical science, particularly in oncology. Breakthrough drugs like Keytruda, Opdivo, and Yervoy have transformed certain cancers from near-certain death sentences into treatable — and sometimes even curable — conditions.

But not every patient benefits from these revolutionary treatments. In a surprising twist a few years ago, researchers discovered an unconventional way to overcome resistance to immunotherapy.

The method? Collecting gut microbes from — yes — poop donated by healthy individuals or patients who've responded well to treatment, and transferring them to those who aren't seeing results. 

"Crazy, right?" Jen Wargo, a professor of surgical oncology and genomic medicine, and the leader of the Platform for Innovative Microbiome and Translational Research at the University of Texas MD Anderson Cancer Center in Houston, tells me. "It's like, who would have thought a poop transplant would work in cancer, you know?" 

The goal is to reshape the microbiome — the vast, intricate community of bacteria, viruses, fungi, and other microbes in the gut that plays a critical role in regulating the immune system and overall health. It turns out that the right mix of gut microbes might be a game-changer in the fight against cancer.

At the same time, studies in this field highlight the benefits of a diet rich in fiber from a variety of whole, plant-based foods and the potential harms of broad-spectrum antibiotics, which can disrupt this delicate ecosystem.

Earlier this month, I wrote extensively in Businessweek about how researchers are hacking the microbiome to transform fecal matter into medicine. Pivotal trials in cancer patients are set to report results early next year, but scientists are also exploring dozens of other potential applications, from diabetes and depression to inflammatory bowel disease and Parkinson's.

While research so far has produced mixed results, progress is accelerating with the help of artificial intelligence. By analyzing large datasets, AI is helping scientists uncover the disease-modifying potential of microbes and their immunological and biological features, paving the way for more targeted treatments. Read my story and see what you think: Gross or good? — Jason Gale

The big story 

Exposure to the Covid virus in utero may have affected children's development, according to a UCLA study, adding to a list of health problems emerging in the wake of the global pandemic. Bloomberg's Jason Gale reports in detail here on the study. 

What we're reading

As 23andMe struggles, another genetic testing company bets on drug discovery, Endpoints News reports

People from India remember life before the polio vaccine. They don't want to go back, says Statnews. 

'Christmas lights' galaxy reveals how Universe formed, the BBC reports

Contact Prognosis

Health questions? Have a tip that we should investigate? Contact us at AskPrognosis@bloomberg.net.

Follow Us

Like getting this newsletter? Subscribe to Bloomberg.com for unlimited access to trusted, data-driven journalism and subscriber-only insights.

Want to sponsor this newsletter?  Get in touch here.

You received this message because you are subscribed to Bloomberg's Prognosis newsletter. If a friend forwarded you this message, sign up here to get it in your inbox.
Unsubscribe
Bloomberg.com
Contact Us
Bloomberg L.P.
731 Lexington Avenue,
New York, NY 10022
Ads Powered By Liveintent Ad Choices

No comments:

Post a Comment

Welcome to RogerScott

Where we’re dedicated to giving you an edge in the daily markets… View in browser View in browser                                     Go...